CREATIVE FINANCIAL DESIGNS INC /ADV
Position in LGND — Ligand Pharmaceuticals Inc
CIK 819864
KOKOMO, IN
Position in LGND
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,160
+$1,164 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#104
of 114 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CREATIVE FINANCIAL DESIGNS INC /ADV holds $72,070 across 25 Biotechnology names. LGND ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28 | $17,459 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
400 | $15,604 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14 | $6,954 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
163 | $5,594 | |
| 5 | ARGX |
Argenx SE
|
4 | $3,711 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
This page
|
10 | $3,160 | |
| 7 | PDSB |
PDS Biotechnology Corp
|
3,000 | $2,643 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
13 | $2,434 |
All Filings in LGND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,160 | 10 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,996 | 10 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,890 | 10 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,771 | 10 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,136 | 10 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,051 | 10 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,143 | 20 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||